A rare side effect to pentavalent vaccine

Authors

  • Rajeshwari S. Gore Department of Pharmacology, Vardhaman Mahavir Medical College, New Delhi, India
  • Yashika R. Garg Department of Pharmacology, Vardhaman Mahavir Medical College, New Delhi, India
  • Sourabh Jain Department of Dermatology, Vardhaman Mahavir Medical College, New Delhi, India
  • Arun Dahiya Department of Pharmacology, Vardhaman Mahavir Medical College, New Delhi, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20162075

Keywords:

Pentavalent, Immunization, Maculopapular

Abstract

A four month old baby experienced itchy reddish raised maculopapular lesions on face, limbs and trunk within 24 hours of immunization with booster dose of pentavalent vaccine. The lesions were not associated with fever, cough, vomiting, or insect bite. There was no similar family history with siblings .There was no history of similar reactions to the previous two doses of the same vaccine. On taking the prescribed medications the lesions subsided in 2-3 days with no recurrence at the time of follow-up.

References

Operational Guidelines Introduction of Haemophilus influenza b (Hib) as Pentavalent Vaccine in Universal Immunization Program of India) World Health Organization, Country office of India, Ministry of Health and Family Welfare, Government of India 2013. Available at: http://www.searo.who.int/india/topics/routine_immunization/Operational_Guidelines_for_introduction_Hib_as_Pentavalent_vaccine_2013.pdf.

Update: vaccine side effects, adverse reactions, contraindication and precautions. Recommendation of Advisory Committee of Immunization Practices (ACIP). Centre for Disease Control and Prevention. Morbidity and Mortality Weekly Report 1996 Sep; 45 (RR-12):1-35. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/00046738.htm.

Immunization Safety Surveillance. Guidelines for immunization programme managers on surveillance of adverse events following immunization World Health Organization Western Pacific Region 2nd Edition. Available at: http://www.wpro.who.int/topics/immunization_safety/ImmunizationSafetySurveillance.pdf.

Chitkara AJ, Thacker N, Vashitha VM, Bansal CR, Gupta SG. Adverse Event Following Immunization (AEFI) Surveillance in India: Position Paper of Indian Academy of Pediatrics, Indian Pediatrics, 2013; 50: 739-741. Available at: http://www.indianpediatrics.net/aug2013/aug-739-741.htm.

Pentavalent vaccine guide for health workers with answers to frequently asked questions. National Rural Health Mission, Ministry of Health and Family Welfare, Government of India 2012. Available at: http://www.searo.who.int/ india/topics/routine_immunization/Pentavalent_vaccine_Guide_for_HWs_with_answers_to_FAQs.pdf.

Pentavalent vaccine in Asian countries, Global Vaccine Safety, Extract from report of GACVS meeting of 12-13 June 2013, published in the WHO Weekly Epidemiological Record on 19 July 2013. Available at: http://www.who.int/vaccine_safety/committee/topics/pentavalent_vaccine/Jul_2013/en/

Sakaguchi M, Nakayama T, Inouye S. Cases of systemic immediate-type urticaria associated with acellular diphtheria-tetanus-pertussis vaccination. Vaccine. 1998;16(11-12):1138-40. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9682371.

Rietschel RL, Adams RM . Reactions to thiomersal in hepatitis B vaccines. Dermatologic Clinics, 1990; 8(1):161-164. Available at: http://europepmc.org/abstract/MED/2137393.

Adverse Events Following Immunization (AEFI):Causality Assessment World Health Organization. Available at: http://whqlibdoc.who.int/aidememoire/a87773_eng.pdf.

Downloads

Published

2016-12-28

How to Cite

Gore, R. S., Garg, Y. R., Jain, S., & Dahiya, A. (2016). A rare side effect to pentavalent vaccine. International Journal Of Community Medicine And Public Health, 3(7), 1972–1974. https://doi.org/10.18203/2394-6040.ijcmph20162075

Issue

Section

Case Reports